期刊文献+

老年高血压伴肥胖患者血清脂联素水平的变化及其临床意义 被引量:3

暂未订购
导出
摘要 目的探讨老年高血压伴肥胖患者血清脂联素水平的变化及其临床意义。方法将符合纳入、排除标准的高血压患者分为高血压肥胖组和单纯高血压组,正常血压者分为单纯肥胖组和正常对照组。高血压的诊断依据2005年中国高血压防治指南诊断标准,肥胖诊断按BMI≥25kg/m2(亚太地区标准)。对所有受试者进行一般检查及血糖、血脂等生化检查,ELISA法测定血清脂联素水平。结果①单纯肥胖组、单纯高血压组、高血压肥胖组BMI、TG、LDL-C均较对照组升高,差异有统计学意义(P<0.05);单纯肥胖组、单纯高血压组、高血压肥胖组HDL-C均较对照组降低,差异有统计学意义(P<0.05);单纯高血压组、高血压肥胖组FPG、SBP、DBP均较对照组增高,差异有统计学意义;高血压肥胖组和单纯高血压组BMI、SBP、DBP较单纯肥胖组增高,差异有统计学意义(P<0.05);高血压肥胖组BMI、FPG、TG、TC较单纯高血压组增高,差异有统计学意义(P<0.05)。②血清脂联素的水平在对照组、单纯肥胖组、单纯高血压组和高血压肥胖组中逐渐降低,且单纯肥胖组、单纯高血压组、高血压肥胖组和对照组比较,单纯高血压组、高血压肥胖组和单纯肥胖组比较,高血压肥胖组和单纯高血压组比较,差异均有统计学意义(P<0.05)。③逐步回归分析示:BMI和DBP与血清脂联素水平呈显著负相关。结论高血压伴肥胖状态下血清脂联素水平明显降低,低脂联素血症和肥胖与高血压密切相关。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第18期2582-2584,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献6

  • 1Iwashima Y,Katsuya T,Ishiawa K,et al.Hypoadiponectinemia is an independent risk factor for hypertension[J].Hypertension,2004;43(6):1318-23.
  • 2Gho YS,Kim PN,Li HC,et al.Stimulation of tumor growth by human soluble intercellular adhesion molecule-1[J].Cancer Res,2001;61(10):4253-7.
  • 3李小平,杨成悌,张灵,常鹏.高血压病患者血清脂联素水平的研究[J].中华心血管病杂志,2004,32(7):596-599. 被引量:37
  • 4Giugliano G,Nicoletti G,Grella E,et al.Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women[J].Br J Plast Surg,2004;57(3):190-4.
  • 5Fruebis J,Tsao TS,Javorschi S,et al.Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J].Proc Nstl Acad Sci USA,2001;98(1):2005-10.
  • 6HUG C,WANG J,AHMAD N,et al.T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin[J].Proc Natl Acad Sci USA,2004;101(28):10308-13.

二级参考文献15

  • 1Scherer PE, Willians S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995,270: 26746-26749.
  • 2Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo), 1996, 120: 803-812.
  • 3Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun, 1999, 257: 79-83.
  • 4Hanley AJ, Connelly PW, Harris SB, et al. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care, 2003, 26: 3219-3225.
  • 5Dzielinska Z, Januszewicz A, Wiecek A, et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res, 2003, 110: 365-369.
  • 6Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-KDa adipocyte complement -related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Nat Acad Sci USA,2001,98:2005-2010.
  • 7Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acety1-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA, 2002, 99 : 16309-16313.
  • 8Yamauchi T, Kamon J, Mizokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 2002, 8: 1288-1295.
  • 9Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation, 1999, 100: 2473-2476.
  • 10Ouchi N, Kihara S, Arita Y, et al. Adipocyte -derived plasma protein, adiponectin suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 103 : 1057-1063.

共引文献36

同被引文献37

  • 1刘艳梅,任向东,刁春英,仇颖,于建成.罗格列酮对单纯性肥胖伴高血压、高三酰甘油血症、高胰岛素血症的临床研究[J].南京医科大学学报(自然科学版),2005,25(6):409-410. 被引量:1
  • 2冯爱萍,马德堂,石云,赵金凤,李梅,李滨,陈岩,秦甫,刘玲玲.Ⅱ型糖尿病患者肺功能改变及相关因素分析[J].河北医学,2005,11(8):699-701. 被引量:11
  • 3王朝迅,裴海成,金红梅,邱明才.超重和肥胖者血清TNF-α、IL-6及CRP与肥胖的关系[J].天津医药,2007,35(5):332-334. 被引量:10
  • 4魏文青.脂联素的研究现状与展望[J].标记免疫分析与临床,2007,14(2):122-125. 被引量:24
  • 5Navaneethan SD,Yehnert H,Moustarah F,et al.Weight loss interventions in chronic kidney disease:a systematic review and metaanalysis[J].Clin J Am Soc Nephrol,2009,4(10):1565-1574.
  • 6Leone N,Courbon D,Thomas F,et al.Lung function impairment and metabolic syndrome the critical role of abdominal obesity[J].Am J Respir Crit Care Med,2009,179(6):509-516.
  • 7Lee JY,Ahn SV,Choi DP,et al.Association between hypertension and pulmonary function in rural adults in Korea[J].J Prev Med Public Health,2009,42(1):21-28.
  • 8Koo HK,Kim DK,Chung HS,et al.Association between metabolic syndrome and rate ofl lung function decline:a longitudinal analysis[J].Int J Tuberc Lung Dis,2013,17(11):1507-1514.
  • 9Kim SI,Han DC,Lee HB.Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells[J].J Am Soc Nephrol,2000,11(1):80-87.
  • 10Lin WY,Yao CA,Wang HC,et al.Impaired lung function is associated with obesity and metabolic syndrome in adults[J].Obesity,2006,14(9):1654-1661.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部